PFIZER INC's Net Worth

$2.44 Billion

Estimate Recalculated Feb 23, 2024 06:01PM EST

Who is PFIZER INC?

PFIZER INC has an estimated net worth of $2.44 Billion. This is based on reported shares across multiple companies, which include BioAtla, Inc., Viatris Inc, Cerevel Therapeutics Holdings, Inc., Cortexyme, Inc., IMARA Inc., SpringWorks Therapeutics, Inc., ICU MEDICAL INC/DE, Allogene Therapeutics, Inc., RHYTHM PHARMACEUTICALS, INC., Mirna Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, Flexion Therapeutics Inc, Celladon Corp, Zoetis Inc., ICAGEN INC, ENCYSIVE PHARMACEUTICALS INC, ARQULE INC, FIVE PRIME THERAPEUTICS INC, KING PHARMACEUTICALS INC, Coley Pharmaceutical Group, Inc., pSivida LTD, INSITE VISION INC, Pyxis Oncology, Inc., Oric Pharmaceuticals, Inc., and Zura Bio Ltd.

SEC CIK

PFIZER INC's CIK is 0000078003

Past Insider Trading and Trends

2008 was PFIZER INC's most active year for acquiring shares with 12 total transactions. PFIZER INC's most active month to acquire stocks was the month of March. 2015 was PFIZER INC's most active year for disposing of shares, totalling 19 transactions. PFIZER INC's most active month to dispose stocks was the month of July. 2011 saw PFIZER INC paying a total of $76,522,164.00 for 12,753,694 shares, this is the most they've acquired in one year. In 2018 PFIZER INC cashed out on 7,385,997 shares for a total of $722,170,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BioAtla, Inc. (BCAB) Snapshot price: $2.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.24M
2.24M
Dec 18
Form 3
0
0
No matching records found

Viatris Inc (VTRS) Snapshot price: $11.89

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-100.00
0
Nov 13 - Nov 16
Form 3
0
0
No matching records found

Cerevel Therapeutics Holdings, Inc. (CERE) Snapshot price: $41.66

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+4.59%
1.2M
$10.00
$12,000,000.00
27.35M
Oct 27
Form 3
0
0
No matching records found

Cortexyme, Inc. (QNCX) Snapshot price: $1.29

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-11.38%
-370.00K
$40.18
-$14,866,600.00
2.88M
Jun 3
Form 4
3.25M
$17.00
$850,000.00
3.25M
May 13
Form 3
0
0
No matching records found

IMARA Inc. (ELVN) Snapshot price: $15.73

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.56M
$16.00
1.56M
Mar 16
Form 3
0
0
No matching records found